Studying tumor proteins in children and young adults with rhabdomyosarcoma
Studies protein patterns in tumor samples from children and young adults with rhabdomyosarcoma.
Plain-language title generated from the registry record
Registry title: Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry
Key facts
- Where
- Lille, FranceSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 0 and 25 years old?
Source: NCT06924463, who can take part
Where in France
- Oscar Lambret CenterLille, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Lille University
- Trial code
- NCT06924463
- Record updated
- 11 April 2025
- Original description
This non-interventional study aims to develop spatial proteomics for analyzing small FFPE tumor samples in rhabdomyosarcoma. It will identify molecular signatures linked to tumor regions, subtypes, survival, and treatment resistance, using pre-existing samples and data.Read full original descriptionShow less
Identification de Signatures moléculaires spécifiques Dans le Rhabdomyosarcome de l'Enfant, de l'Adolescent et du Jeune Adulte, Par Analyse Spatiale du protéome Par spectrométrie de Masse
This non-interventional study aims to develop spatial proteomics for analyzing small FFPE tumor samples in rhabdomyosarcoma. It will identify molecular signatures linked to tumor regions, subtypes, survival, and treatment resistance, using pre-existing samples and data.
Inclusion: Age between 0 and 25 years at the time of initial diagnosis; Diagnosis of rhabdomyosarcoma confirmed histologically; Care at the Oscar Lambret Center between January 2005 and November 2024; No objection to the re-use of data and biological samples collected as part of care for research activities.
Exclusion: Unavailability of biological sample in FFPE from biopsy and/or surgical specimen for diagnosis at Centre Oscar Lambret; Patient under guardianship or trusteeship.